Ads
related to: alnylam pharmaceuticals cambridge ma careers applicationus.jobrapido.com has been visited by 1M+ users in the past month
- Jobs in Georgia
Explore the latest jobs
Check them and Apply now
- Jobs in North Carolina
245 Vacancies available
in your City. Don't miss any.
- Latest Jobs in Texas
Find out your Dream Job
Sign Up for free
- Jobs in New York City, ny
Find the right Opportunity
for You
- Jobs in Georgia
Large Employment Site (>10 Million Unique Visitors Per Month) - TAtech
Search results
Results from the WOW.Com Content Network
Alnylam Pharmaceuticals, Inc. is an American biopharmaceutical company focused on the discovery, development and commercialization of RNA interference (RNAi) therapeutics [3] for genetically defined diseases. The company was founded in 2002 and is headquartered in Cambridge, Massachusetts. [4]
Wanting to "impact more than the hundred or so patients I would see in a year", Greenstreet switched career, gaining a master's degree at the INSEAD Business School in France. In 1992, she joined the pharmaceutical firm Glaxo, which later became GlaxoSmithKline (GSK). [ 1 ]
CAMBRIDGE, Mass.--(BUSINESS WIRE)-- Alnylam Pharmaceuticals, Inc. (NAS: ALNY) , a leading RNAi therapeutics company, announced today that it has filed a Clinical Trial Application (CTA) with the U ...
Zamore's research has led to a career in biotechnology, co-founding Alnylam Pharmaceuticals in 2002. [5] Alnylam is dedicated to bringing RNAi based therapies to market and developed the first-ever FDA approved RNAi drug, Patisiran, gaining FDA approval in August 2018. [6]
PARSIPPANY, N.J. & CAMBRIDGE, Mass.--(BUSINESS WIRE)-- The Medicines Company (NAS: MDCO) and Alnylam Pharmaceuticals, Inc. (NAS: ALNY) , a leading RNAi therapeutics company, announced today that ...
Alnylam plans to file an investigational new drug (IND) application for ALN-AT3 in the fourth quarter of 2013 and initiate a Phase I clinical trial in early 2014.
Pages in category "Companies based in Cambridge, Massachusetts" ... Alnylam Pharmaceuticals; ... ARC/Architectural Resources Cambridge, Inc. ARIAD Pharmaceuticals;
Shares of Alnylam Pharmaceuticals (NASDAQ: ALNY), a biotech company developing a new class of medications based on RNAi technology, have soared 250% since the start of 2013. Why are investors so ...